华博生物医药技术

Huabo Biopharm Co., Ltd., a wholly owned subsidiary of Huahai Pharmaceutical, is a start-up biotech company dedicated to discovery, development, and commercializing of breakthrough therapies with the potential to deliver meaningful clinical benefit to tumor patients. We are currently advancing a pipeline of promising preclinical candidates and have robust research capabilities fuelling our long-term growth. To meet the fast advancement of project R&D, we are looking for two top managers who will fill the positions of chief scientific officer (CSO) and vice president (VP) respectively. The candidates should have solid background in cell biology, or antibody development, or cell line generation and cell line processing, and have comprehensive experiences in biological drug development in industrial area abroad.